ODI Pharma AB: Publication of half-year report 2021
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2021. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Second quarter (2021-10-01 – 2021-12-31) The Group's net sales amounted to SEK 458,620 (0). The Group's loss after financial items amounted to SEK -2,049,565 (-771,779). Result per share amounted to SEK -0.13 (-0.05).* The solidity as of 2021-12-31 was 93 % (98 %).** Six months (2021-07-01 – 2021-12-31) The